BIOMAT Database Logo BIOMAT Database Logo

Prevention of cytomegalovirus disease by Towne strain live attenuated vaccine. 1984

S A Plotkin, and M L Smiley, and H M Friedman, and S E Starr, and G R Fleisher, and C Wlodaver, and D C Dafoe, and A D Friedman, and R A Grossman, and C F Barker

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003586 Cytomegalovirus Infections Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults. CMV Inclusion,CMV Inclusions,Congenital CMV Infection,Congenital Cytomegalovirus Infection,Cytomegalic Inclusion Disease,Cytomegalovirus Colitis,Cytomegalovirus Inclusion,Cytomegalovirus Inclusion Disease,Cytomegalovirus Inclusions,Inclusion Disease,Perinatal CMV Infection,Perinatal Cytomegalovirus Infection,Renal Tubular Cytomegalovirus Inclusion,Renal Tubular Cytomegalovirus Inclusions,Salivary Gland Virus Disease,Severe Cytomegalovirus Infection,Severe Cytomegalovirus Infections,Infections, Cytomegalovirus,CMV Infection, Congenital,CMV Infection, Perinatal,Colitis, Cytomegalovirus,Congenital CMV Infections,Congenital Cytomegalovirus Infections,Cytomegalic Inclusion Diseases,Cytomegalovirus Colitides,Cytomegalovirus Inclusion Diseases,Cytomegalovirus Infection,Cytomegalovirus Infection, Congenital,Cytomegalovirus Infection, Perinatal,Cytomegalovirus Infection, Severe,Cytomegalovirus Infections, Severe,Disease, Cytomegalic Inclusion,Disease, Cytomegalovirus Inclusion,Diseases, Cytomegalovirus Inclusion,Inclusion Disease, Cytomegalic,Inclusion Disease, Cytomegalovirus,Inclusion Diseases,Inclusion Diseases, Cytomegalovirus,Inclusion, CMV,Inclusion, Cytomegalovirus,Infection, Congenital CMV,Infection, Congenital Cytomegalovirus,Infection, Cytomegalovirus,Infection, Perinatal CMV,Infection, Perinatal Cytomegalovirus,Infection, Severe Cytomegalovirus,Perinatal CMV Infections,Perinatal Cytomegalovirus Infections
D003587 Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS. Herpesvirus 5, Human,Human Herpesvirus 5,Salivary Gland Viruses,HHV 5,Herpesvirus 5 (beta), Human,Cytomegaloviruses,Salivary Gland Virus,Virus, Salivary Gland,Viruses, Salivary Gland
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations
D014613 Vaccines, Attenuated Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity. Attenuated Vaccine,Vaccines, Live, Attenuated,Attenuated Vaccines,Vaccine, Attenuated
D014765 Viral Vaccines Suspensions of attenuated or killed viruses administered for the prevention or treatment of infectious viral disease. Viral Vaccine,Vaccine, Viral,Vaccines, Viral

Related Publications

S A Plotkin, and M L Smiley, and H M Friedman, and S E Starr, and G R Fleisher, and C Wlodaver, and D C Dafoe, and A D Friedman, and R A Grossman, and C F Barker
Immunisation trials with live attenuated cytomegalovirus TOWNE 125.
January 1975, Infection,
S A Plotkin, and M L Smiley, and H M Friedman, and S E Starr, and G R Fleisher, and C Wlodaver, and D C Dafoe, and A D Friedman, and R A Grossman, and C F Barker
Specific cellular and humoral immunity after immunization with live Towne strain cytomegalovirus vaccine.
April 1981, The Journal of infectious diseases,
S A Plotkin, and M L Smiley, and H M Friedman, and S E Starr, and G R Fleisher, and C Wlodaver, and D C Dafoe, and A D Friedman, and R A Grossman, and C F Barker
A CMV DNA vaccine primes for memory immune responses to live-attenuated CMV (Towne strain).
March 2009, Vaccine,
S A Plotkin, and M L Smiley, and H M Friedman, and S E Starr, and G R Fleisher, and C Wlodaver, and D C Dafoe, and A D Friedman, and R A Grossman, and C F Barker
Safety and immunogenicity of the Towne strain cytomegalovirus vaccine.
March 1998, The Pediatric infectious disease journal,
S A Plotkin, and M L Smiley, and H M Friedman, and S E Starr, and G R Fleisher, and C Wlodaver, and D C Dafoe, and A D Friedman, and R A Grossman, and C F Barker
Cytomegalovirus vaccine virus (Towne strain) does not induce latency.
August 1985, The Journal of infectious diseases,
S A Plotkin, and M L Smiley, and H M Friedman, and S E Starr, and G R Fleisher, and C Wlodaver, and D C Dafoe, and A D Friedman, and R A Grossman, and C F Barker
Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trial.
April 1991, Annals of internal medicine,
S A Plotkin, and M L Smiley, and H M Friedman, and S E Starr, and G R Fleisher, and C Wlodaver, and D C Dafoe, and A D Friedman, and R A Grossman, and C F Barker
A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne).
September 1999, The Journal of infectious diseases,
S A Plotkin, and M L Smiley, and H M Friedman, and S E Starr, and G R Fleisher, and C Wlodaver, and D C Dafoe, and A D Friedman, and R A Grossman, and C F Barker
Avidity maturation following immunization with two human cytomegalovirus (CMV) vaccines: a live attenuated vaccine (Towne) and a recombinant glycoprotein vaccine (gB/MF59).
January 2003, Viral immunology,
S A Plotkin, and M L Smiley, and H M Friedman, and S E Starr, and G R Fleisher, and C Wlodaver, and D C Dafoe, and A D Friedman, and R A Grossman, and C F Barker
Humoral immune response to cytomegalovirus Towne vaccine strain and to Toledo low-passage strain.
May 1989, The Journal of infectious diseases,
S A Plotkin, and M L Smiley, and H M Friedman, and S E Starr, and G R Fleisher, and C Wlodaver, and D C Dafoe, and A D Friedman, and R A Grossman, and C F Barker
Multicenter trial of Towne strain attenuated virus vaccine in seronegative renal transplant recipients.
December 1994, Transplantation,
Copied contents to your clipboard!